234 related articles for article (PubMed ID: 7059438)
41. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
[TBL] [Abstract][Full Text] [Related]
42. Impairment of antipyrine clearance in humans by propranolol.
Greenblatt DJ; Franke K; Huffman DH
Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
[TBL] [Abstract][Full Text] [Related]
43. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
44. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
Shaw PN; Hall ST; Houston JB
Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
[TBL] [Abstract][Full Text] [Related]
45. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.
Teunissen MW; Willemse PH; Sleijfer DT; Sluiter WJ; Breimer DD
Cancer Chemother Pharmacol; 1984; 13(3):181-5. PubMed ID: 6207949
[TBL] [Abstract][Full Text] [Related]
46. Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
Buchanan N; Davis M; Danhof M; Breimer DD
Br J Clin Pharmacol; 1980 Oct; 10(4):363-8. PubMed ID: 7448107
[TBL] [Abstract][Full Text] [Related]
47. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
48. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
[TBL] [Abstract][Full Text] [Related]
49. Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
Schellens JH; van der Wart JH; Brugman M; Breimer DD
J Pharmacol Exp Ther; 1989 May; 249(2):638-45. PubMed ID: 2724144
[TBL] [Abstract][Full Text] [Related]
50. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
[TBL] [Abstract][Full Text] [Related]
51. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
52. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
Sharer JE; Wrighton SA
Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065
[TBL] [Abstract][Full Text] [Related]
53. Physical exercise and improvement of liver oxidative metabolism in the elderly.
Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
[TBL] [Abstract][Full Text] [Related]
54. The effect of enzyme induction on diazepam metabolism in man.
Ohnhaus EE; Park BK; Colombo JP; Heizmann P
Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
[TBL] [Abstract][Full Text] [Related]
55. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
Tanaka E; Nakamura K
Eur J Clin Pharmacol; 1989; 36(6):629-32. PubMed ID: 2776822
[TBL] [Abstract][Full Text] [Related]
56. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
57. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
58. Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography.
Inaba T; Fischer NE
Can J Physiol Pharmacol; 1980 Jan; 58(1):17-21. PubMed ID: 7378903
[TBL] [Abstract][Full Text] [Related]
59. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
Palette C; Cordonnier P; Naline E; Advenier C; Pays M
J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
[TBL] [Abstract][Full Text] [Related]
60. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
